Results 201 to 210 of about 54,427 (263)

Cardiovascular Morbidity in Juvenile-Onset Systemic Lupus Erythematosus

openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Outcomes in juvenile onset lupus: single center cohort from a developing country

Lupus, 2018
Introduction About 10–20% of systemic lupus erythematosus (SLE) patients have onset in childhood and have more severe organ involvement. Survival of juvenile SLE patients is improving worldwide.
A. Aggarwal, S. Phatak, Pramod K. Srivastava, Able Lawrence, V. Agarwal, R. Misra   +5 more
semanticscholar   +3 more sources

Association of microRNA-125a with the clinical features, disease activity and inflammatory cytokines of juvenile-onset lupus patients

Lupus, 2021
Background Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with marked variation in its clinical presentation. Juvenile-onset SLE (jSLE) exhibits an aggressive clinical phenotype and severe complications.
E. Eissa, B. Morcos, Rania Fawzy Mahmoud Abdelkawy, H. Ahmed, N. Kholoussi   +4 more
semanticscholar   +1 more source

Neuropsychiatric Involvement in Juvenile-Onset Systemic Lupus Erythematosus: A Multicenter Study.

Joint Bone Spine, 2023
Neuropsychiatric (NP) involvement is a restricted area in juvenile-onset systemic lupus erythematosus (jSLE).To investigate the prevalence, demographic and clinical features, and outcomes of the neurological involvement in the Turkish jSLE population.This study was based upon 24 referral centers' SLE cohorts, multicenter and multidisciplinary network ...
A. Kısaarslan, S. Çiçek, E. D. Batu, S. Şahin, M. Gürgöze, Sibel Balcı Çetinkaya, Miray Kışla Ekinci, B. Atmis, K. Barut, A. Adroviç, Buket Esen Ağar, Nihal Şahin, F. Demir, Esra Bağlan, M. Kara, Senay Zirhli Selcuk, S. Özdel, E. Çomak, Betül Akkoyunlu, G. O. Yener, Deniz Gezgin Yıldırım, Kübra Öztürk, M. Yıldız, F. Haşlak, S. Şener, H. Kısaoğlu, Özge Baba, Zehra Kızıldağ, Rana İşgüder, Ş. Çağlayan, R. B. Güven Bilgin, Gülçin Aytaç, B. Yücel, Ayşe Tanatar, H. E. Sönmez, M. Çakan, A. Kara, A. Elmas, B. Kiliç, N. Ayaz, B. Kasap, B. Acar, O. Ozkaya, S. Yüksel, S. Bakkaloğlu, Özlem Aydoğ, G. Aksu, S. Akman, O. Dönmez, M. Bülbül, M. Büyükçelik, Y. Tabel, B. Sözeri, M. Kalyoncu, Y. Bilginer, M. Poyrazoğlu, E. Ünsal, Ö. Kasapçopur, S. Özen, R. Düşünsel   +59 more
semanticscholar   +12 more sources

Low disease activity state in juvenile-onset systemic lupus erythematosus

Lupus, 2021
Objectives To determine the rate of achieving The Lupus Low Disease Activity State (LLDAS) in children with systemic lupus erythematosus (SLE) for tracing pertinent treatment modalities. Methods A total of 122 juvenile-onset SLE (jSLE) patients from six pediatric rheumatology centers in Turkey were enrolled in the study.
Kubra Ozturk, Senğul Caglayan, Ayse Tanatar, Esra Baglan, Gulcin Yener Otar, Gulsah Kavrul Kayaalp, Serife Gul Karadag, Ferhat Demir, Hafize Emine Sonmez, Semanur Ozdel, Mustafa Cakan, Nuray Aktay Ayaz, Betul Sozeri   +12 more
openaire   +3 more sources

Outcome in juvenile onset systemic lupus erythematosus

Current Opinion in Rheumatology, 2005
Over the past 2 decades, there has been a marked improvement in survival among patients with juvenile-onset systemic lupus erythematosus. As a result of the increased life expectancy, children and adolescents with systemic lupus erythematosus are now faced with considerable morbidity resulting from sequelae of disease activity, side effects of ...
RAVELLI, ANGELO, RUPERTO N, MARTINI, ALBERTO   +2 more
openaire   +3 more sources

Treatment Options for Juvenile-Onset Systemic Lupus Erythematosus

Pediatric Drugs, 2002
Systemic lupus erythematosus (SLE) is an inflammatory chronic disease characterized by the presence of activated helper T-cells that induce a B-cell response, resulting in the secretion of pathogenic autoantibodies and the formation of immune complexes.
Luis, Carreño, Francisco Javier, López-Longo, Carlos Manuel, González, Indalecio, Monteagudo   +3 more
openaire   +2 more sources

Pulmonary hypertension in juvenile-onset systemic lupus erythematosus: a case series

Clinical and Experimental Rheumatology, 2022
Systemic lupus erythematosus (SLE) is a rare multisystem autoimmune disorder with a variable clinical phenotype. Pulmonary hypertension (PHTN) is a recognised (and not uncommonly asymptomatic) complication of the condition with an associated poor prognosis in adults.
Platt, Caroline, Longthorpe, Catherine, Sit, Jacqueline, Marks, Stephen D, Harmer, Matthew, Ciurtin, Coziana, Ramanan, Athimalaipet V, Beresford, Michael W   +7 more
openaire   +3 more sources